{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:42:48Z","timestamp":1793292168346,"version":"4.5.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1053\/j.semnuclmed.2021.04.005","type":"journal-article","created":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T02:10:38Z","timestamp":1622599838000},"page":"474-484","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["PET\/CT Variants and Pitfalls in Breast Cancers"],"prefix":"10.1053","volume":"51","author":[{"given":"Elias George","family":"Kikano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Avril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Stanley","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto J.","family":"Montero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Avril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0001","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2214\/AJR.19.21177","article-title":"PET\/CT for patients with breast cancer: where is the clinical impact?","volume":"213","author":"Ulaner","year":"2019","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0002","doi-asserted-by":"crossref","first-page":"17S","DOI":"10.2967\/jnumed.115.157859","article-title":"F-18 FDG PET\/CT for staging and restaging of breast cancer","volume":"57","author":"Groheux","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0003","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0004","first-page":"438","article-title":"Breast cancer statistics, 2019","volume":"69","author":"DeSantis","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0005","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0006","first-page":"7","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0007","doi-asserted-by":"crossref","first-page":"279","DOI":"10.7326\/M15-2886","article-title":"Screening for breast cancer: u.s. preventive services task force recommendation statement","volume":"164","author":"Siu","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0008","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0009","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMra031301","article-title":"Ductal carcinoma in situ of the breast","volume":"350","author":"Burstein","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0010","first-page":"9","article-title":"Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis","volume":"42","author":"Avril","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0011","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/annonc\/mdv221","article-title":"Tailoring therapies\u2013improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015","volume":"26","author":"Coates","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0012","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"Sorlie","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0013","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","article-title":"The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups","volume":"486","author":"Curtis","year":"2012","journal-title":"Nature"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0014","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1158\/1055-9965.EPI-17-0627","article-title":"Differences in breast cancer survival by molecular subtypes in the united states","volume":"27","author":"Howlader","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0015","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1200\/JCO.2015.65.2289","article-title":"Use of biomarkers to guide decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer: american society of clinical oncology clinical practice guideline","volume":"34","author":"Harris","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0016","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1200\/JCO.2000.18.20.3495","article-title":"Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations","volume":"18","author":"Avril","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0017","doi-asserted-by":"crossref","first-page":"S383","DOI":"10.1016\/j.jacr.2017.08.044","article-title":"ACR appropriateness criteria((R)) breast cancer screening","volume":"14","author":"Expert Panel on Breast","year":"2017","journal-title":"J Am Coll Radiol"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0018","doi-asserted-by":"crossref","first-page":"452","DOI":"10.6004\/jnccn.2020.0016","article-title":"Breast cancer, version 3.2020, nccn clinical practice guidelines in oncology","volume":"18","author":"Gradishar","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0019","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/AOG.0000000000002158","article-title":"Practice bulletin number 179: breast cancer risk assessment and screening in average-risk women","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0020","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1001\/jama.2015.12783","article-title":"Breast cancer screening for women at average risk: 2015 guideline update from the american cancer society","volume":"314","author":"Oeffinger","year":"2015","journal-title":"JAMA"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0021","first-page":"43","article-title":"American cancer society\/american society of clinical oncology breast cancer survivorship care guideline","volume":"66","author":"Runowicz","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0022","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s11307-009-0294-0","article-title":"Degree of tumor FDG uptake correlates with proliferation index in triple negative breast cancer","volume":"12","author":"Tchou","year":"2010","journal-title":"Mol Imaging Biol"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0023","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00259-002-0880-8","article-title":"FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters","volume":"29","author":"Buck","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0024","first-page":"11","article-title":"Oncogenic signaling in tumorigenesis and applications of sirna nanotherapeutics in breast cancer","author":"Kamaruzman","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0025","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/bcr2558","article-title":"Key signalling nodes in mammary gland development and cancer. Signalling downstream of PI3 kinase in mammary epithelium: a play in 3 Akts","volume":"12","author":"Wickenden","year":"2010","journal-title":"Breast Cancer Res"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0026","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/modpathol.3800525","article-title":"The Akt pathway in human breast cancer: a tissue-array-based analysis","volume":"19","author":"Bose","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0027","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s11604-017-0707-y","article-title":"Simultaneous whole-body and breast 18F-FDG PET\/MRI examinations in patients with breast cancer: a comparison of apparent diffusion coefficients and maximum standardized uptake values","volume":"36","author":"Sasaki","year":"2018","journal-title":"Jpn J Radiol"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0028","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1470-7330-14-13","article-title":"The utility of 18 F-FDG PET\/CT for suspected recurrent breast cancer: impact and prognostic stratification","volume":"14","author":"Cochet","year":"2014","journal-title":"Cancer Imaging"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0029","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s00259-013-2553-1","article-title":"Breast cancer detection using high-resolution breast PET compared to whole-body PET or PET\/CT","volume":"41","author":"Kalinyak","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0030","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10549-016-3908-7","article-title":"Standardized measures of lobular involution and subsequent breast cancer risk among women with benign breast disease: a nested case-control study","volume":"159","author":"Figueroa","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0031","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/RLU.0b013e318217569e","article-title":"Rapidly growing complex fibroadenoma with surrounding ductal hyperplasia mimics breast malignancy on serial F-18 FDG PET\/CT imaging","volume":"36","author":"Makis","year":"2011","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0032","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s11604-009-0335-2","article-title":"Mastopathic-type fibroadenoma and ductal adenoma of the breast with false-positive fluorodeoxyglucose positron emission tomography","volume":"27","author":"Yamaguchi","year":"2009","journal-title":"Jpn J Radiol"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0033","doi-asserted-by":"crossref","first-page":"k2387","DOI":"10.1136\/bmj.k2387","article-title":"Prevalence and outcomes of incidental imaging findings: umbrella review","volume":"361","author":"O'Sullivan","year":"2018","journal-title":"BMJ"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0034","first-page":"24","article-title":"Multicentric study on (1)(8)F-FDG-PET\/CT breast incidental uptake in patients studied for non-breast malignant purposes","volume":"34","author":"Bertagna","year":"2015","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4048\/jbc.2015.18.1.73","article-title":"Incidental breast lesions identified by (18)f-fdg pet\/ct: which clinical variables differentiate between benign and malignant breast lesions?","volume":"18","author":"Shin","year":"2015","journal-title":"J Breast Cancer"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0036","first-page":"105","article-title":"Fat necrosis may mimic local recurrence of breast cancer in FDG PET\/CT","volume":"32","author":"Akkas","year":"2013","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0037","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/RLU.0b013e31828e9948","article-title":"Diffuse FDG uptake due to fat necrosis following transverse rectus abdominus myocutaneous (TRAM) flap reconstruction","volume":"38","author":"Dobbs","year":"2013","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0038","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.ejrad.2014.02.010","article-title":"Benign breast lesions detected by positron emission tomography-computed tomography","volume":"83","author":"Benveniste","year":"2014","journal-title":"Eur J Radiol"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0039","doi-asserted-by":"crossref","first-page":"W390","DOI":"10.2214\/AJR.13.11758","article-title":"Breast emergencies: types, imaging features, and management","volume":"202","author":"Mahoney","year":"2014","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0040","doi-asserted-by":"crossref","first-page":"W304","DOI":"10.2214\/AJR.11.7130","article-title":"False-positive lesions mimicking breast cancer on FDG PET and PET\/CT","volume":"198","author":"Adejolu","year":"2012","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0041","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00003072-200002000-00003","article-title":"F-18 FDG uptake in breast infection and inflammation","volume":"25","author":"Bakheet","year":"2000","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0042","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/SLA.0000000000002990","article-title":"US FDA breast implant postapproval studies: long-term outcomes in 99,993 patients","volume":"269","author":"Coroneos","year":"2019","journal-title":"Ann Surg"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0043","first-page":"S261","article-title":"Imaging spectrum of extracapsular silicone: correlation of US, MR imaging, mammographic, and histopathologic findings","author":"Caskey","year":"1999","journal-title":"Radiographics"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0044","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3348\/kjr.2009.10.2.194","article-title":"A false positive F-FDG PET\/CT scan caused by breast silicone injection","volume":"10","author":"Chen","year":"2009","journal-title":"Korean J Radiol"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0045","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1148\/rg.255045122","article-title":"FDG PET of infection and inflammation","volume":"25","author":"Love","year":"2005","journal-title":"Radiographics"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0046","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1148\/rg.242025724","article-title":"An introduction to PET-CT imaging","volume":"24","author":"Kapoor","year":"2004","journal-title":"Radiographics"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0047","doi-asserted-by":"crossref","first-page":"117e","DOI":"10.1097\/01.PRS.0000122408.60459.92","article-title":"Breast augmentation: cancer concerns and mammography-a literature review","volume":"113","author":"Jakubietz","year":"2004","journal-title":"Plast Reconstr Surg"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0048","doi-asserted-by":"crossref","first-page":"W1031","DOI":"10.2214\/AJR.11.7216","article-title":"Challenges in mammography: part 2, multimodality review of breast augmentation\u2013imaging findings and complications","volume":"197","author":"Venkataraman","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0049","first-page":"13","article-title":"Diagnostic accuracy of positron emission mammography with (18)f-fluorodeoxyglucose in breast cancer tumor of less than 20 mm in size","volume":"7","author":"Yano","year":"2019","journal-title":"Asia Ocean J Nucl Med Biol"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0050","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/RLU.0000000000001203","article-title":"spectrum of the breast lesions with increased 18f-fdg uptake on pet\/ct","volume":"41","author":"Dong","year":"2016","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0051","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1002\/1097-0142(197206)29:6<1691::AID-CNCR2820290637>3.0.CO;2-4","article-title":"Cancers metastatic to the breast","volume":"29","author":"Hajdu","year":"1972","journal-title":"Cancer"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0052","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12957-016-0915-4","article-title":"Non-primary breast malignancies: a single institution's experience of a diagnostic challenge with important therapeutic consequences-a retrospective study","volume":"14","author":"Buisman","year":"2016","journal-title":"World J Surg Oncol"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0053","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/modpathol.2012.191","article-title":"Non-mammary metastases to the breast and axilla: a study of 85 cases","volume":"26","author":"DeLair","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0054","article-title":"Thyroid carcinoma presenting as metastatic disease to the breast","volume":"2020","author":"Kanteti","year":"2020","journal-title":"Case Rep Pathol"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0055","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s00259-009-1145-6","article-title":"Diagnostic value of full-dose FDG PET\/CT for axillary lymph node staging in breast cancer patients","volume":"36","author":"Heusner","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0056","doi-asserted-by":"crossref","first-page":"23","DOI":"10.21873\/invivo.12228","article-title":"Specificity and the diagnostic accuracy of pet\/ct for axillary staging in patients with stage i-iii cancer: a systematic review of the literature","volume":"35","author":"Kasem","year":"2021","journal-title":"In Vivo"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0057","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/RLU.0000000000003633","article-title":"18F-FDG-Avid lymph nodes after COVID-19 vaccination on 18F-FDG PET\/CT","volume":"46","author":"Ulaner","year":"2021","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0058","doi-asserted-by":"crossref","DOI":"10.2967\/jnmt.121.262008","article-title":"Reactive axillary lymphadenopathy to COVID-19 vaccination on F18-FDG PET\/CT","author":"Smith","year":"2021","journal-title":"J Nucl Med Technol"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0059","first-page":"148","article-title":"Generalized lymph node activation after influenza vaccination on (18)f FDG-PET\/CT imaging, an important pitfall in PET interpretation","volume":"5","author":"Ayati","year":"2017","journal-title":"Asia Ocean J Nucl Med Biol"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0060","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317728285","article-title":"18F-FDG PET\/CT in breast cancer: Evidence-based recommendations in initial staging","volume":"39","author":"Caresia Aroztegui","year":"2017","journal-title":"Tumour Biol"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0061","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.2967\/jnumed.108.052050","article-title":"Breast cancer staging in a single session: whole-body PET\/CT mammography","volume":"49","author":"Heusner","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0062","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ijrobp.2008.02.056","article-title":"Effect of (18)F-FDG PET\/CT imaging in patients with clinical Stage II and III breast cancer","volume":"71","author":"Groheux","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0063","first-page":"1455","article-title":"18F-FDG PET for staging breast cancer in patients with inner-quadrant versus outer-quadrant tumors: comparison with long-term clinical outcome","volume":"46","author":"Tran","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0064","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2967\/jnumed.111.093864","article-title":"The yield of 18F-FDG PET\/CT in patients with clinical stage IIA, IIB, or IIIA breast cancer: a prospective study","volume":"52","author":"Groheux","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0065","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0093-7754(03)00094-0","article-title":"The follow-up of breast cancer","volume":"30","author":"Emens","year":"2003","journal-title":"Semin Oncol"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0066","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/MNM.0b013e3283516716","article-title":"Clinical utility of F-18 FDG PET\/CT in recurrent breast carcinoma","volume":"33","author":"Manohar","year":"2012","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0067","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/cncr.25727","article-title":"Breast cancer recurrence diagnosis suspected on tumor marker rising: value of whole-body 18FDG-PET\/CT imaging and impact on patient management","volume":"117","author":"Champion","year":"2011","journal-title":"Cancer"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0068","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ejrad.2008.10.031","article-title":"Integrated contrast-enhanced diagnostic whole-body PET\/CT as a first-line restaging modality in patients with suspected metastatic recurrence of breast cancer","volume":"73","author":"Dirisamer","year":"2010","journal-title":"Eur J Radiol"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0069","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejrad.2007.10.021","article-title":"Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT","volume":"65","author":"Schmidt","year":"2008","journal-title":"Eur J Radiol"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0070","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1200\/JCO.2015.63.5185","article-title":"[18F]Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET)\/Computed Tomography (CT) in Suspected Recurrent Breast Cancer: A Prospective Comparative Study of Dual-Time-Point FDG-PET\/CT, Contrast-Enhanced CT, and Bone Scintigraphy","volume":"34","author":"Hildebrandt","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0071","doi-asserted-by":"crossref","first-page":"S779","DOI":"10.21037\/jtd.2017.12.126","article-title":"Diagnostic performance of fluorine-18 fluorodeoxyglucose positron emission tomography in the management of solitary pulmonary nodule: a meta-analysis","volume":"10","author":"Divisi","year":"2018","journal-title":"J Thorac Dis"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0072","doi-asserted-by":"crossref","first-page":"e12518","DOI":"10.1097\/MD.0000000000012518","article-title":"Everolimus-induced pulmonary toxicity: Findings on 18F-FDG PET\/CT imaging","volume":"97","author":"Dejust","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0073","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1200\/JCO.2014.59.4358","article-title":"Immune checkpoint blockade in cancer therapy","volume":"33","author":"Postow","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0074","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0075","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1158\/1078-0432.CCR-16-3001","article-title":"Breast Cancer Immunotherapy: Facts and Hopes","volume":"24","author":"Emens","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0076","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1001\/jamaoncol.2020.2535","article-title":"Association of event-free and distant recurrence-free survival with individual-level pathologic complete response in neoadjuvant treatment of stages 2 and 3 breast cancer: three-year follow-up analysis for the i-spy2 adaptively randomized clinical trial","volume":"6","author":"Consortium","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0077","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1007\/s00259-017-3802-5","article-title":"Clinical characteristics of patient selection and imaging predictors of outcome in solid tumors treated with checkpoint-inhibitors","volume":"44","author":"Rossi","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0078","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9030890","article-title":"In Which Patients with Sarcoidosis Is FDG PET\/CT Indicated?","volume":"9","author":"Keijsers","year":"2020","journal-title":"J Clin Med"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0079","article-title":"Another \"great mimicker\": FDG-PET\/CT imaging findings of sarcoid-like reaction","volume":"1","author":"Kendi","year":"2015","journal-title":"BJR Case Rep"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0080","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/2193-1801-2-113","article-title":"FDG-PET\/CT of sarcoidosis and sarcoid reactions following antineoplastic treatment","volume":"2","author":"Inoue","year":"2013","journal-title":"Springerplus"},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0081","unstructured":"Available at: https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/drug-trial-snapshot-cerianna."},{"key":"10.1053\/j.semnuclmed.2021.04.005_bib0082","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.2967\/jnumed.116.175596","article-title":"18F-fluoroestradiol PET: current status and potential future clinical applications","volume":"57","author":"Liao","year":"2016","journal-title":"J Nucl Med"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299821000210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299821000210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:38:41Z","timestamp":1757543921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299821000210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":82,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0001299821000210"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2021.04.005","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PET\/CT Variants and Pitfalls in Breast Cancers","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2021.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}